Results 21 to 30 of about 47,170 (292)

A study on the Development of Biopharmaceutical Companies Based on the Context of Big Data [PDF]

open access: yesBIO Web of Conferences, 2023
Based on the requirements of the computer technology background in the new era, this paper takes Chinese biopharmaceutical enterprises as the research object, outlines the general characteristics of innovation in Chinese biopharmaceutical enterprises ...
Li Weichao
doaj   +1 more source

Plasmid Biopharmaceuticals

open access: yesMicrobiology Spectrum, 2014
ABSTRACTPlasmids are currently an indispensable molecular tool in life science research and a central asset for the modern biotechnology industry, supporting its mission to produce pharmaceutical proteins, antibodies, vaccines, industrial enzymes, and molecular diagnostics, to name a few key products.
Duarte Miguel F, Prazeres   +1 more
openaire   +2 more sources

Cell-free protein synthesis: advances on production process for biopharmaceuticals and immunobiological products

open access: yesBioTechniques, 2021
Biopharmaceutical products are of great importance in the treatment or prevention of many diseases and represent a growing share of the global pharmaceutical market.
Camila Hiromi Chiba   +4 more
doaj   +1 more source

SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?

open access: yesПедиатрическая фармакология, 2013
A considerable number of biopharmaceuticals have recently been introduced into clinical practice. Their role is becoming more and more important in managing various diseases, including incapacitating and life-threatening diseases.
A. S. Kolbin, A. V. Kharchev
doaj   +1 more source

Single-use systems in biopharmaceutical manufacture : state of the art and recent trends

open access: yes, 2023
Single-use systems have become increasingly important in recent years. This applies in particular to their use in the manufacture of biopharmaceutical products based on mammalian cell cultures, such as antibodies for the therapy of cancer and autoimmune ...
Jossen, Valentin   +3 more
core   +1 more source

Comparing Multi-Label Classification Methods for Provisional Biopharmaceutics Class Prediction. [PDF]

open access: yes, 2014
The biopharmaceutical classification system (BCS) is now well established and utilized for the development and biowaivers of immediate oral dosage forms. The prediction of BCS class can be carried out using multilabel classification.
Taravat Ghafourian   +8 more
core   +1 more source

Inclusion of unexposed subjects improves the precision and power of self-controlled case series method

open access: yes, 2021
10.1080/10543406.2021.1998099Journal of Biopharmaceutical Statistics322277 ...
Cheung, Yin Bun   +5 more
core   +1 more source

Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?

open access: yesVertigO, 2009
During the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector.
Marie-Hélène Bacon
doaj   +1 more source

Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies

open access: yesMolecules, 2020
Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR).
Camille Lombard-Banek, John E. Schiel
doaj   +1 more source

Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects

open access: yesFrontiers in Plant Science, 2022
Glycoproteins are the dominant category among approved biopharmaceuticals, indicating their importance as therapeutic proteins. Glycoproteins are decorated with carbohydrate structures (or glycans) in a process called glycosylation.
Alex van der Kaaij   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy